David Mawufemor Azilagbetor

Mr. David Mawufemor Azilagbetor

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2024 in Animals
Verified
Journal Article
Open access
PDF file
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
DSDavid Shaw
David Shaw
BEBernice Simone Elger
Bernice Simone Elger
The use of nonhuman animals in biomedical research is regulated under stringent conditions, not only in response to societal attitudes towards animal experimentation but also because ethical responsibility in scientific research requires researchers and veterinarians to be more invested and aim to improve the welfare of animals used for experiments. Analyses of animal research oversight reveal the frequent approval of experiments, and the approval of some experiments has raised and continues to raise public concerns. Societal compliance is required for a consensus-based approach to animal research policy, prompting the need to have transparent discussions about oversight and the frequency of approvals. We discuss how frequent approval may be perceived and why it seems problematic from a societal perspective: the regulatory process exists to approve only legitimate experiments. Although some experiments remain unacceptable irrespective of their harm–benefit ratios, almost all experiments are approved. We explain some possible legitimate reasons for frequent approval and how the review process could be leading to the approval of illegitimate studies. To ensure transparency and improve public trust and understanding of oversight, we propose the adoption of a platform to inform society about how unethical experiments are screened out.

25 December 2024 in Heliyon
Verified
Journal Article
Open access
NNNesisa Analisa Nyathi
Nesisa Analisa Nyathi
Walter MusakwaWalter Musakwa
Walter Musakwa
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
NKNikolaus J. Kuhn
Nikolaus J. Kuhn
Nature plays a crucial role in providing ecosystem services (ESs) essential for human wellbeing and biodiversity conservation in rural areas. However, existing paradigms often lack an integrative approach towards rural livelihoods and wellbeing, highlighting the need for a comprehensive understanding of the relationship between human wellbeing (HWB) and ESs. The area around the Greater Limpopo Transfrontier Conservation Area (GLTFCA) offers such ESs to indigenous people who rely heavily on these natural resources. Thus, this study aimed to quantify indigenous people's perceptions of cultural and provisioning ESs and their link to human wellbeing in villages adjacent to the GLTFCA. Key informant interviews were initially conducted to identify ESs as perceived by the participants. Subsequently, face-to-face surveys were carried out in 9 wards across South Africa and Zimbabwe, involving 350 participants. Respondents were asked about the availability of ESs, their levels of degradation, drivers of change, and the impact on their wellbeing. Responses were captured using Likert scales, and multiple regression models analysed the relationships between socio-demographic characteristics and ESs. Results indicated that indigenous people perceived both cultural and provisioning ESs to be available but degrading, with provisioning services degrading more rapidly. Climate change, legislation/policies, and poverty were identified as key drivers of this change. Socio-demographic factors such as gender, nativeness, and employment level influenced perceptions of both ESs. Overall, participants reported that both ESs contribute to their human wellbeing and livelihoods through life satisfaction, happiness, living standards, safety, security, and good health. Finally, this study's findings uniquely offer a baseline for these ESs accounting, demonstrating their direct and indirect benefits to indigenous communities' livelihoods and well-being.

16 March 2025 in Alternatives to Laboratory Animals
Verified
Journal Article
Open access
MDManeesha Deckha
Maneesha Deckha
MMMargot Michel
Margot Michel
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
CBCharlotte Blattner
Charlotte Blattner
RMRosa Maria Cajiga Morales
Rosa Maria Cajiga Morales
Miriam A. ZemanovaMiriam A. Zemanova
Miriam A. Zemanova
This report is a result of an interdisciplinary workshop held at the Collegium Helveticum in Zurich, Switzerland in February 2024, in which ideas for accelerating NAMs (New Approach Methodologies) in Swiss universities were shared and discussed. Due to regional differences in university organisation and funding structures, not all recommendations will be transferable to all regions worldwide. All participants were qualified to contribute to the discussion, due to their knowledge and experience of the Three Rs, in particular with regard to their implementation. The workshop participants believed that universities, which play a pioneering role in so many other areas, should also exploit their innovative potential in the field of animal-free research. The workshop uncovered four areas that would need to be addressed in order to achieve a significant change in university science culture and do more justice to the Three Rs, namely: language — innovative framing (pro-replacement framing in official university statements); knowledge transfer — communicating innovative findings in teaching (redirecting curriculum); change of values within science faculties; and structured implementation and well-coordinated planning of the transformation (establishment of a ‘transition unit’). Specific strategies for implementing these four areas are outlined. In addition, we discuss why the replacement of animal testing should be an essential goal for universities, why this goal has not yet been achieved, and why concerted efforts toward change are required.

21 March 2024 in BMC Nursing
Verified
Journal Article
Open access
PDF file
CFChaima Fihri Fassi
Chaima Fihri Fassi
YMYasmine Mourajid
Yasmine Mourajid
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
ASAsma Sabri
Asma Sabri
MCMohamed Chahboune
Mohamed Chahboune
AHAbderraouf Hilali
Abderraouf Hilali
Promoting patient safety is a critical concern for developing-countries health systems like Morocco. There is an increasing acknowledgment of the need to create a patient-centered culture with the aim to decrease the number of adverse events related to care and improve health-care quality in Morocco. The purpose of this study is to examine the perceptions of health professionals working in primary care level of care facilities in Morocco about the concept of patient safety culture. We conducted a multicentric cross-sectional study of a quantitative nature in primary healthcare facilities in ten Moroccan cities, measuring ten patient safety culture dimensions, from February 2022 to June 2022. Data was collected using the French version of the HSOPSC questionnaire. The most developed dimension of the culture of patient safety was found to be Teamwork within Units (69%), followed by Supervisor/Manager’s Expectations & Actions Promoting Patient Safety (59%). The least developed dimensions were Staffing (34%) and Nonpunitive Response to Errors (37%). Improving patient safety culture should be a priority for primary healthcare facility administrators and all stakeholders, addressing, in particular, the shortage of human resources. In addition, health personnel should be encouraged to report errors without fear of punitive consequences.

27 November 2025 in Alternatives to Laboratory Animals
Verified
Journal Article
Open access
Francesca PistollatoFrancesca Pistollato
Francesca Pistollato
FFFabia Furtmann
Fabia Furtmann
MSMarco Straccia
Marco Straccia
MAMarc Avey
Marc Avey
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
HCHelder Costantino
Helder Costantino
Recent global initiatives are accelerating the shift toward human-centric approaches, reducing reliance on animal models in preclinical research and other domains. In this changing landscape, objectively evaluating the scientific relevance and merit of research involving animal models, and assessing their translational relevance is increasingly critical. Over the past decade, several tools have been developed to assess translational relevance, accuracy/appropriateness and efficacy of preclinical animal models, evaluate risk-of-bias in preclinical research, support harm–benefit analyses, and facilitate the adoption of non-animal replacement strategies. However, the uptake of such tools remains limited. To address this, a Biomedical Research for the 21st Century (BioMed21) Collaboration workshop on ‘Evaluating translational value of animal models in preclinical research — Tools, challenges, and strategies’, was convened by Humane World for Animals (30 June–1 July 2025). The event brought together tool developers and diverse global interest-holders to review current assessment tools, discuss their strengths, complementarity, limitations and feasibility, and explore opportunities for cross-sector collaboration. This paper summarises key outcomes of these presentations and discussions, highlighting knowledge gaps and barriers to the adoption of these tools and frameworks by researchers, funders and regulators. Strategies to raise awareness and promote the use of the tools and frameworks, to better inform funding decisions, regulatory approval and the appraisal of preclinical research, are also proposed.

13 August 2025 in Medicine, Health Care and Philosophy
Verified
Journal Article
Open access
David Mawufemor AzilagbetorDavid Mawufemor Azilagbetor
David Mawufemor Azilagbetor
GDGail Davies
Gail Davies
LGLester Darryl Geneviève
Lester Darryl Geneviève
DSDavid Martin Shaw
David Martin Shaw
BEBernice Simone Elger
Bernice Simone Elger
Doing scientific research with animals is a subject of intense societal debate, often involving polarized and public discussions with stakeholders and groups interested in animal research. Patients, given their medical conditions, have a high stake in biomedical research, including research involving animals. However, their perspectives are rarely heard in policy-related discussions on animal experiments. This essay discusses the positions and stakes of groups involved in public discourse and policy-relevant engagements. It further explores the legitimate interest of patients and the need for an all-inclusive approach to animal research policy. This subject is complex and democratic societies must address societal issues with an all-inclusive approach to reach policy decisions reflecting the interests of all stakeholders. The positions of groups—pro-animal research stakeholders and anti-animal-research advocates—with vested interests involved in animal research discourse considerably shape research policies. Animal research policies arguably affect patients. Through democratic ideals, inclusive approaches that are suitable for resolving science-driven societal issues, and initiatives currently guiding animal research policies, patients need to actively be involved in public discourses and policy-relevant decision-making processes in deciding the place of animal research in biomedical advancement as a society.